SpaceXs Public Debut Raises Sector Classification Question Industrials Tech or Telecommunications
ONGC Shares Decline 35 on Q4 Results Amid Production Declines and Higher Writeoffs
OpenAI Takes Early Lead in AI IPO Race as Confidential Filing Reports Emerge
US GDP Growth Revised Lower to 16 in First Quarter 2026 Amid Profit Slowdown
US Crude and Gasoline Inventories Extend Decline Tightening Supply Outlook
Indian Bond Bull Market Pause Possible But Cycle Not Over Say Experts
TISI Q1 2026 Earnings Deep EPS Loss Weighs on Sentiment as Stock Slips
American Healthcare REIT Inc AHR Q1 2026 Earnings Strong EPS Beat Amidst Operational Improvements
AIHS Q1 2026 Earnings Continued Losses Amid Challenging Market Conditions
Oragenics Q2 2023 Earnings Narrowing Loss Surprises No Revenue Yet
BWIN Q1 2026 Earnings EPS Misses Estimates Stock Rises on Operational Progress
ICMB Q3 2025 Earnings EPS Falls Short of Estimates Stock Edges Higher
Hawkins Inc HWKN Posts Solid Gains Approaching Key Resistance Amid Strong Momentum
Skye Bioscience SKYE Holds Above Support After Modest Gain
Akari Therapeutics AKTX Plunges 126 Amid Heightened Biotech Volatility
Gulf Resources Inc GURE Slides 209 as Selling Pressure Intensifies Near Support Levels
Coeptis Therapeutics Holdings Warrants COEPW Hold Steady at 001 Amid Thin Trading
Teslas Musk Cites China as Top Rival in Humanoid Robot Race Amid Beijings Workforce Training Push
PHUN Q1 2026 Earnings NarrowerThanExpected Loss but Revenue Uncertainty Lingers
DENTSPLY SIRONa XRAY Tests Key Support as Selling Pressure Persists
RZB Q1 2026 Earnings Strong Earnings Beat Bolsters Credit Profile
eToro Group Ltd Q1 2026 Earnings EPS Beats Estimates by 234 Shares Rise
Edison International EIX Q1 2026 Earnings EPS Beats Estimates by 712 as Utility Operations Strengthen
KPTI Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Confidence
VICI Q1 2026 Earnings Earnings Beat Estimate by 144 Modest Stock Reaction
Aterian Inc ATER Q3 2025 Earnings Significant EPS Beat Drives Optimism
PDS Biotechnology Q1 2026 Earnings EPS Beat on Narrower Loss Clinical Progress in Focus